share_log

爱博医疗(688050.SH):有晶体眼人工晶体(PR)产品仍在审批过程中

eyebright medical technology (beijing) co., ltd. (688050.SH): the crystalline artificial crystalline (PR) product is still in the approval process.

Gelonghui Finance ·  Oct 16 04:47

Gelonghui October 16th | Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) stated on the investor interaction platform that the company's intraocular lens artificial lens (PR) product is still in the approval process, not yet certified for listing, and it is inconvenient to disclose the business plan. The company will continue to fully utilize its own technological and academic promotion advantages, as well as the synergies of various business lines, to expand brand influence, enhance recognition at the level of doctors, patients, and consumers, continuously consolidate and increase market share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment